Pharmaceutical compositions comprising bupropion and cysteine
A bupropion-cysteine molecular complex stabilizes bupropion in pharmaceutical compositions, addressing instability issues and enhancing therapeutic efficacy for neurological and psychiatric conditions.
US12661408B2Active Publication Date: 2026-06-23ANTECIP BIOVENTURES II LLC
Patent Information
- Authority / Receiving Office
- US · United States
- Patent Type
- Patents(United States)
- Current Assignee / Owner
- ANTECIP BIOVENTURES II LLC
- Filing Date
- 2025-06-13
- Publication Date
- 2026-06-23
Smart Images
Figure US12661408-C00001
Abstract
This disclosure relates to pharmaceutical compositions comprising bupropion and cysteine, and pharmaceutical dosage forms comprising bupropion and cysteine. The disclosure also relates to molecular complexes of bupropion and cysteine. These compositions and dosage forms may have improved stability of bupropion.
Need to check novelty before this filing date? Find Prior Art